BFSP1: The Potential Drug Target and Biomarker for Stroke (G631)

Target Name: BFSP1

NCBI ID: G631

BFSP1

BFSP1: The Potential Drug Target and Biomarker for Stroke

Stroke is a leading cause of morbidity and mortality worldwide, affecting over 40 million people each year. The most common type of stroke is ischemic stroke, which occurs when the blood flow to the brain is blocked, leading to cell death and potential brain damage. While there are several treatments available for ischemic stroke, the availability of effective drugs is limited. Therefore, there is a need for new targets and biomarkers for stroke that can aid in the development of new treatments.

BFSP1: The Transcript Variant 1 of Beaded Filament Structural Protein 1 (BFSP1)

BFSP1 is a protein that is expressed in various tissues and cells, including the brain. It is a member of the filament family of proteins, which are involved in the structure and organization of tissues and cells. BFSP1 has been shown to play a role in the development and progression of ischemic stroke.

Recent studies have shown that BFSP1 is involved in the regulation of blood-brain barrier (BBB) function, which is the barrier that separates the brain from the blood. The BBB is designed to prevent the entry of harmful substances into the brain, but it also allows necessary substances to enter. However, when the BBB is compromised, it can allow harmful substances to enter the brain and contribute to stroke development.

BFSP1 has also been shown to play a role in the regulation of axon growth and differentiation. When axons (the long, flexible projections of neurons) grow and differentiate, they can help to repair damaged tissue and promote the formation of new neural networks. However, in stroke, the axons can become damaged or misrouted, leading to persistent neural deficits.

Drugs that target BFSP1 have the potential to aid in the development of new treatments for ischemic stroke. By inhibiting BFSP1 function, drugs can reduce the formation of new blood-brain barrier, allowing for the entry of harmful substances and contributing to stroke development. Additionally, by promoting the growth and differentiation of axons, drugs can help to repair damaged tissue and promote the formation of new neural networks.

Conclusion

In conclusion, BFSP1 is a protein that has been shown to play a role in the development and progression of ischemic stroke. By inhibiting BFSP1 function, drugs have the potential to aid in the development of new treatments for this debilitating and often fatal condition. Further research is needed to fully understand the role of BFSP1 in stroke and to develop effective drugs that target this protein.

Protein Name: Beaded Filament Structural Protein 1

Functions: Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA (PubMed:28935373). Involved in altering the calcium regulation of MIP water permeability (PubMed:30790544)

The "BFSP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BFSP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets